Literature DB >> 24633360

Epidemiology and the economic assessment of a mumps outbreak in a highly vaccinated population, Orange County, New York, 2009-2010.

Preeta Krishnan Kutty1, Jacqueline Lawler2, Elizabeth Rausch-Phung3, Ismael R Ortega-Sanchez1, Stephen Goodell2, Cynthia Schulte3, Lynn Pollock3, Barbara Valure2, Jean Hudson2, Kathleen Gallagher1, Debra Blog3.   

Abstract

Studies assessing the economic burden of a mumps outbreak in a highly vaccinated population are limited. The Orange County Health Department (OCHD), New York State Department of Health (NYS DOH), and the Centers for Disease Control and Prevention conducted a mumps investigation in an affected village with a highly vaccinated population. To understand the epidemiology, standardized mumps case definition and active surveillance were used to identify mumps cases. In addition, an economic assessment of a combined outbreak investigation and third dose measles-mumps-rubella (MMR) vaccine intervention conducted by OCHD and NYS DOH was performed; estimated by retrospectively evaluating public health response-related activities including use of a third dose of MMR vaccine. From September 24, 2009, through June 15, 2010, 790 mumps cases were reported-64% were male and highest attack rate was among 11-17 year age group (99.1 cases per 1000 individuals). Of the 658 cases with known vaccination history, 83.6% had documentation of 2 doses of mumps containing vaccine. No deaths were reported. The 2 major exposure settings were schools (71.8%) and households (22.5%). Approximately 7736 h of public health personnel time were expended with the total approximate cost of US $463,000, including US $34,392 for MMR vaccine-the estimated cost per household was US $827. Mumps continues to be endemic in many parts of the world, resulting in importations into the United States. Large mumps outbreaks similar to this in highly vaccinated populations may require considerable investigation and control activities.

Entities:  

Keywords:  economic; highly vaccinated; mumps; outbreak; vaccine

Mesh:

Substances:

Year:  2014        PMID: 24633360      PMCID: PMC4896528          DOI: 10.4161/hv.28389

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  39 in total

1.  Summary of notifiable diseases--United States, 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-06-14       Impact factor: 17.586

2.  Summary of notifiable diseases--United States, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-05-02       Impact factor: 17.586

3.  Notice to readers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-06-09       Impact factor: 17.586

4.  Environmental factors potentially associated with mumps transmission in yeshivas during a mumps outbreak among highly vaccinated students: Brooklyn, New York, 2009-2010.

Authors:  Amy Parker Fiebelkorn; Jennifer B Rosen; Cedric Brown; Christopher M Zimmerman; Hyman Renshowitz; Christopher D'Andrea; Kathleen M Gallagher; Rafael Harpaz; Jane R Zucker
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

5.  The effect of a school entry law on mumps activity in a school district.

Authors:  B P Chaiken; N M Williams; S R Preblud; W Parkin; R Altman
Journal:  JAMA       Date:  1987-05-08       Impact factor: 56.272

6.  Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009.

Authors:  Jennifer S Rota; Jennifer B Rosen; Margaret K Doll; Rebecca J McNall; Marcia McGrew; Nobia Williams; Elena N Lopareva; Albert E Barskey; Amado Punsalang; Paul A Rota; William R Oleszko; Carole J Hickman; Christopher M Zimmerman; William J Bellini
Journal:  Clin Vaccine Immunol       Date:  2013-01-16

7.  Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006.

Authors:  J S Rota; J C Turner; M K Yost-Daljev; M Freeman; D M Toney; E Meisel; N Williams; S B Sowers; L Lowe; P A Rota; L A Nicolai; L Peake; W J Bellini
Journal:  J Med Virol       Date:  2009-10       Impact factor: 2.327

8.  Mumps vaccine performance among university students during a mumps outbreak.

Authors:  Margaret M Cortese; Hannah T Jordan; Aaron T Curns; Patricia A Quinlan; Kim A Ens; Patricia M Denning; Gustavo H Dayan
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

9.  Recent resurgence of mumps in the United States.

Authors:  Gustavo H Dayan; M Patricia Quinlisk; Amy A Parker; Albert E Barskey; Meghan L Harris; Jennifer M Hill Schwartz; Kae Hunt; Carol G Finley; Dennis P Leschinsky; Anne L O'Keefe; Joshua Clayton; Lon K Kightlinger; Eden G Dietle; Jeffrey Berg; Cynthia L Kenyon; Susan T Goldstein; Shannon K Stokley; Susan B Redd; Paul A Rota; Jennifer Rota; Daoling Bi; Sandra W Roush; Carolyn B Bridges; Tammy A Santibanez; Umesh Parashar; William J Bellini; Jane F Seward
Journal:  N Engl J Med       Date:  2008-04-10       Impact factor: 91.245

10.  The role of schools in the spread of mumps among unvaccinated children: a retrospective cohort study.

Authors:  Wilhelmina L M Ruijs; Jeannine L A Hautvast; Reinier P Akkermans; Marlies E J L Hulscher; Koos van der Velden
Journal:  BMC Infect Dis       Date:  2011-08-24       Impact factor: 3.090

View more
  8 in total

1.  Characteristics of a large mumps outbreak: Clinical severity, complications and association with vaccination status of mumps outbreak cases.

Authors:  C Stein Zamir; H Schroeder; H Shoob; N Abramson; G Zentner
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control.

Authors:  Cristina V Cardemil; Rebecca M Dahl; Lisa James; Kathleen Wannemuehler; Howard E Gary; Minesh Shah; Mona Marin; Jacob Riley; Daniel R Feikin; Manisha Patel; Patricia Quinlisk
Journal:  N Engl J Med       Date:  2017-09-07       Impact factor: 91.245

Review 3.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

4.  2016-2017 Arkansas mumps outbreak in a close-knit community: Assessment of the economic impact and response strategies.

Authors:  Jamison Pike; Mona Marin; Angela Guo; Dirk Haselow; Haytham Safi; Fangjun Zhou
Journal:  Vaccine       Date:  2019-12-06       Impact factor: 3.641

5.  Vaccines for measles, mumps, rubella, and varicella in children.

Authors:  Carlo Di Pietrantonj; Alessandro Rivetti; Pasquale Marchione; Maria Grazia Debalini; Vittorio Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2020-04-20

6.  Epidemiological features and sociodemographic factors associated with mumps in mainland China from 2004 to 2018.

Authors:  Xiaofang Fu; Minjie Ge; Wucheng Xu; Min Yu; Jiangang Ju; Yonghong Zhong; Huaqiong Huang
Journal:  J Med Virol       Date:  2022-07-09       Impact factor: 20.693

7.  Cost of Public Health Response and Outbreak Control With a Third Dose of Measles-Mumps-Rubella Vaccine During a University Mumps Outbreak-Iowa, 2015-2016.

Authors:  Mona Marin; Tricia L Kitzmann; Lisa James; Patricia Quinlisk; Wade K Aldous; John Zhang; Cristina V Cardemil; Chris Galeazzi; Manisha Patel; Ismael R Ortega-Sanchez
Journal:  Open Forum Infect Dis       Date:  2018-10-04       Impact factor: 3.835

8.  Current views and advances on Paediatric Virology: An update for paediatric trainees.

Authors:  Ioannis N Mammas; Anne Greenough; Maria Theodoridou; Anna Kramvis; Iliana Christaki; Chryssie Koutsaftiki; Maria Koutsaki; Dimitra M Portaliou; Georgia Kostagianni; Paraskevi Panagopoulou; George Sourvinos; Demetrios A Spandidos
Journal:  Exp Ther Med       Date:  2015-11-24       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.